Q-Hairgrowth
Serum
A Multi-Targeted Topical Therapy for Hair Fall Control and Follicular Regeneration. Clinical Evaluation of Safety and Efficacy in Male Subjects with Hair Fall and Early Alopecia.
"Advanced hair regrowth through follicular science."
by Week 3
Clinical Study
Complete Results
Events
Executive Summary
Clinically Proven
Hair Fall Control
Q-Hairgrowth Serum is a scientifically engineered, multi-component topical formulation designed to activate hair follicle stem cells (HFSCs), inhibit DHT-mediated follicular miniaturization, reduce oxidative stress, and restore the scalp microenvironment.
8-Week Human Clinical Study
The results validate Q-Hairgrowth as an advanced non-drug topical therapy for hair fall control and follicular rejuvenation.
A prospective, open-label, single-arm 8-week human clinical study in 40 male subjects aged 25–40 years conducted in compliance with ICH-GCP principles.
The formulation's multi-pathway approach — combining antioxidants, peptides, botanical DHT blockers, and microcirculatory enhancers — creates a regenerative follicular environment, rather than a purely stimulatory effect.
1. Clinical Background & Unmet Need
Why Hair Loss
Requires a Multi-Target Approach
Alopecia affects 60–70% of adult males worldwide, with onset frequently beginning between 25–40 years. Male pattern hair loss is driven by a multifactorial pathophysiology.
2. Scientific Rationale
5 Core Mechanistic
Pillars
Q-Hairgrowth was formulated as a multi-pathway biological system designed to restore the follicular ecosystem rather than merely stimulate hair shafts. This integrated strategy aligns with current advances in hair biology emphasizing HFSC reactivation.
3. Investigational Product Overview
Functional Ingredient
Architecture
Q-Hairgrowth Serum is a topical formulation comprising six functional ingredient categories working in synergy to address every pathway of hair loss.
- Redensyl® (patented HFSC activator)
- Biotinyl-GHK (bioactive peptide complex)
- Saw palmetto extract
- Biochanin-rich isoflavones
- Trifolium pratense (red clover)
- Resveratrol · Quercetin · Astaxanthin
- Lycopene · Beta-carotene · CoQ10
- Zinc · L-arginine · L-lysine
- L-tryptophan · N-acetyl cysteine
- Cedarwood · Castor · Coconut · Cinnamon
- Olive · Sesame · Bay oil
- Trigonella · Bacopa · Gotu kola
- Punica granatum · Papaya · Rosemary
4–5. Clinical Study Design & Protocol
Rigorous Clinical Evaluation
— 8 Weeks, 40 Subjects
| Study Period | Frequency | Contact Time |
|---|---|---|
| Week 1 | Once daily | 3–4 hours |
| Week 2 | Alternate days | 3–4 hours |
| Weeks 3–8 | Twice weekly | 3–4 hours |
6. Clinical Endpoints
Efficacy & Safety
Measurement Framework
Subjects were instructed not to wash the scalp during the application window. All assessments were conducted at baseline, Week 3, Week 6, and Week 8.
- Hair fall count (comb test)
- Hair density (investigator scoring)
- Hair shaft thickness
- New hair growth (vellus → terminal)
- Scalp irritation assessment
- Redness, itching, burning
- Adverse event reporting
7. Clinical Results
Hair Fall Reduction &
Density Recovery Over 8 Weeks
| Parameter | Baseline | Week 3 | Week 8 |
|---|---|---|---|
| Hair fall | 90–130/day | 10–30/day | 2–8/day |
| Scalp visibility | High | Moderate | Minimal |
| Hair density | Low | Moderate | High |
Hair Growth & Density Timeline
8. Safety & Tolerability
Excellent Safety Profile
Across All 40 Subjects
Q-Hairgrowth Serum demonstrated an outstanding safety profile throughout the 8-week study period with no clinically significant adverse effects.
Advanced Hair Regrowth
Through Follicular Science
Q-Hairgrowth Serum is a scientific-grade cosmeceutical for hair fall control and early-stage alopecia, designed to activate hair follicle stem cells, modulate DHT, and restore the scalp microenvironment through a multi-target, technology-driven approach.
Contact the Medical Team